Carloni, S., Facchinetti, F., Pelizzi, N., Buonocore, G
GLP1/E, at very low doses, is sufficient to ameliorate PCOS-associated metabolic alterations Since GLP1/E was superior to any other compound in terms of improvement of metabolic traits, we next assessed the metabolic efficacy of very low doses of this multi-agonist in our metabolically dysregulated PCOS model
By week 8, regain had begun and was significant (+1.50 kg versus control), rising to +2.50 kg by week 20
Hexarelin human studies have used intravenous and subcutaneous doses roughly in the 1 to 2 mcg/kg range
Immunoassays and Emerging Technologies Conventional immunoassays rely on antibodies to flag target molecules
I recommend following a healthy Mediterranean-style diet and exercising regularly with aerobic and strength training